Wednesday’s landslide defeat for President Moon’s Democratic Party (DP) in key mayoral elections in Korea suggest that it faces an uphill battle to retain the presidency in next year’s vote. Defeat next year would have implications for economic policy and Korea’s relationship with China.
Doubts about the safety of the AstraZeneca jab present a further challenge to Asia’s already-slow vaccine rollout. AstraZeneca accounts for the bulk of vaccine orders made by Thailand, Sri Lanka and Bangladesh.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to gain:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services